Decoding resistance in Diutina catenulata by validating clinically relevant Erg11/Fks1 mutations
Open Access
- 17 February 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1776442
Abstract
Objective: To verify the causal relationship between specific mutations in the ERG11 and FKS1 genes and antifungal drug resistance in clinical isolates of Diutina catenulata . Methods: Recombinant plasmids expressing mutant alleles of ERG11 (F126L, K143R) or FKS1 (F621I, S1123G, I1348S, and the triple mutant S625L/S1123G/F1354L) were constructed and functionally validated in a Saccharomyces cerevisiae W303-1a model. Susceptibility testing was performed under different nutrient conditions (SD-Ura and YPD). Molecular docking analysis was conducted to elucidate the structural mechanisms of resistance. Results: Functional validation in S. cerevisiae confirmed that both ERG11 and FKS1 mutations conferred resistance in a nutrient-dependent manner. The ERG11 -F126L mutation increased the fluconazole MIC by 21-fold in SD-Ura compared to YPD. FKS1 mutations led to 1.4 to 2-fold increases in echinocandin MICs. Molecular docking revealed the mechanistic bases: ERG11 -F126L expanded the ligand-binding cavity (ΔΔG +1.2 kcal/mol), FKS1 -F621I disrupted hydrophobic interactions, and compound mutations synergistically perturbed ATP-binding domains. Conclusion: Specific mutations in ERG11 (F126L, K143R) and FKS1 (F621I and hotspot variants) are the primary drivers of the pronounced antifungal resistance observed in Chinese D. catenulata strains, with resistance phenotypes being modulated by nutrient availability.Keywords
This publication has 27 references indexed in Scilit:
- Decreased DMI sensitivity of Plenodomus biglobosus (phoma of oilseed rape) associated with CYP51 substitution G476SPest Management Science, 2025
- Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51)Journal of Medicinal Chemistry, 2025
- Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness costNature Microbiology, 2024
- A Cluster of Diutina catenulata Funguria in Patients with Coronavirus Disease 2019 (COVID-19) Hospitalized in a Tertiary Reference Hospital from Rio de Janeiro, BrazilCurrent Microbiology, 2024
- Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated ResistanceAngewandte Chemie International Edition, 2024
- Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samplesClinical Microbiology and Infection, 2022
- Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infectionsMicrobial Pathogenesis, 2022
- A gain-of-function mutation in PDR1 of Candida glabrata decreases EPA1 expression and attenuates adherence to epithelial cells through enhancing recruitment of the Mediator subunit Gal11AMicrobiological Research, 2020
- Resistance of Candida to azoles and echinocandins worldwideClinical Microbiology and Infection, 2019
- Genomic reconstruction to improve bioethanol and ergosterol production of industrial yeast Saccharomyces cerevisiaeJournal of Industrial Microbiology and Biotechnology, 2015